How Will the Arrhythmia Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the arrhythmia market size evolved in recent years?
The size of the arrhythmia market has expanded considerably in recent years. The market which was valued at $7.8 billion in 2024 is projected to reach $8.35 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.0%. The historical growth can be linked to factors such as a growth in lifestyle-related risks, an increase in cardiovascular ailments, advancements in implantable devices, a worldwide rise in heart surgeries, a growing need for remote monitoring, and ongoing research and development in the field of antiarrhythmic drugs.
What are the predictions for the arrhythmia market size in the coming years?
A significant expansion is anticipated in the arrhythmia market over the coming years. The market’s size is projected to reach $11.83 billion in 2029, with a compounded annual growth rate (CAGR) of 9.1%. Factors contributing to the predicted momentum during the forecast period include increased knowledge and awareness, personalized treatment strategies, the growth of electrophysiology laboratories, emphasis on early detection and prevention, screening for hereditary arrhythmias, and advancements in healthcare infrastructure. Key trends to watch during this forecast period include developments in cardiac monitoring technology, the adoption of telehealth and remote patient monitoring, heightened attention to atrial fibrillation (AF) detection and management, incorporation of implantable devices for managing arrhythmia, innovations in ECG monitor devices, and a regulatory emphasis on the approval of medical devices.
Get your arrhythmia market report here!
https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report
What key factors are fueling the growth of the arrhythmia market?
The growth of the arrhythmia market is envisioned to be driven by the escalating occurrence of heart ailments and other cardiac issues. Cardiac disease, further known as cardiovascular disease, encompasses a range of conditions involving the heart and blood vessels, including atherosclerosis, strokes, heart attacks, and arrhythmias, to name a few. Both functional impairments, such as diastolic and systolic dysfunction, and electrical failures, like the onset of arrhythmias, can contribute to a high incidence of heart failure, atrial fibrillation, and other heart-related diseases. For instance, the Centers for Disease Control and Prevention, a US-based government entity, reported in October 2022 that there were an estimated 69.7k deaths related to heart disease annually and 80.5k heart attacks every year in the United States. [i] Consequently, the escalating occurrence of heart ailments and other cardiac conditions are facilitating the expansion of the arrhythmia market.
How is the global arrhythmia market divided into key segments?
The arrhythmia market covered in this report is segmented –
1) By Type: Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias, Other Types
2) By Test Equipment: Electrocardiogram (ECG), Holter Monitor
3) By Hearth Blocks: First Degree Heart Block, Second Degree Heart Block, Third Degree Heart Block
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Supraventricular Tachycardias: Atrial Fibrillation, Atrial Flutter, Paroxysmal Supraventricular Tachycardia (PSVT)
2) By Ventricular Arrhythmias: Ventricular Fibrillation, Ventricular Tachycardia, Premature Ventricular Contractions (PVCs)
3) By Bradyarrhythmias: Sinus Bradycardia, Heart Block
4) By Other Types: Long QT Syndrome, Wolff-Parkinson-White Syndrome, Torsades de Pointes
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8018&type=smp
Who are the key firms paving the way for growth in the arrhythmia market?
Major companies operating in the arrhythmia market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AliveCor Inc., Biotronik SE & Co. KG, Biotricity Inc., GE Healthcare, Koninklijke Philips N.V., Nihon Kohden Corporation, Spacelabs Healthcare, Welch Allyn Inc., Mylan N.V., Lepu Medical Technology Co. Ltd., iRhythm Technologies Inc., BioTelemetry Inc., Fukuda Denshi Co. Ltd., Smart Solutions Technologies Inc., Biosense Webster Inc., Cardiac Science Corporation, CardioComm Solutions Inc., CardioNet LLC, NUUBO SMART SOLUTIONS S.L., Cardiva Medical Inc., Osypka AG, Johnson & Johnson Services Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd, Applied Cardiac Systems, Acutus Medical, EP Solutions SA
Which trends are expected to transform the arrhythmia market?
The arrhythmia market is seeing an upward trend in new treatment methods. Leading companies in the field are making strides in creating innovative therapies, with cryoablation therapy being a notable example for treating arrhythmia patients. Let’s take GE HealthCare, a US medical technology company, who in August 2023 unveiled their CardioVisio for Atrial Fibrillation. This is a digital tool focusing on patients, designed to deliver precision care by using advanced data analytics and patient information to assist medical professionals in understanding and managing the prevalent heart condition, atrial fibrillation. With personalized treatment plans and real-time data monitoring, this tool is geared towards heightening the credibility of treatment choices and enhancing patient results, positioning them at the forefront of cardiac care management advancements.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8018
What regions are contributing significantly to the growth of the arrhythmia market?
North America was the largest region in the arrhythmia market in 2024. The regions covered in the arrhythmia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Electrophysiology Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
